Cetirizine hydrochloride - HIVES
NDC 70010-293, Cetirizine hydrochloride, tablet, coated, from Granules Pharmaceuticals Inc..
- Product NDC
- 70010-293
- Status
- Listed
- Labeler
- Granules Pharmaceuticals Inc.
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA209274
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70010-293 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CETIRIZINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70010-293-10 | 70010029310 | 1000 TABLET, COATED in 1 BOTTLE (70010-293-10) |
| 70010-293-14 | 70010029314 | 14 TABLET, COATED in 1 BOTTLE (70010-293-14) |
| 70010-293-79 | 70010029379 | 13 BLISTER PACK in 1 CARTON (70010-293-79) / 10 TABLET, COATED in 1 BLISTER PACK (70010-293-56) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 70010-293 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70010-293 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70010-293. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.